# An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

> **NCT02290301** · — · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 5180 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** gemigliptin

## Key facts

- **NCT ID:** NCT02290301
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-28
- **Primary completion:** 2017-11-30
- **Final completion:** 2017-11-30
- **Target enrollment:** 5180 (ACTUAL)
- **Last updated:** 2019-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02290301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02290301, "An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02290301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*